Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2026-03-04 @ 3:14 PM
Study NCT ID:
NCT00664105
Status:
TERMINATED
Last Update Posted:
2012-09-07
First Post:
2008-04-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-02
Start Date Type:
None
Primary Completion Date:
2008-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-06
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-19
First Submit QC Date:
None
Study First Post Date:
2008-04-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-09-30
Results First Submit QC Date:
None
Results First Post Date:
2011-03-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-30
Last Update Post Date:
2012-09-07
Last Update Post Date Type:
ESTIMATED